Time to discontinuation of first- and second-generation antipsychotic medications in the treatment of schizophrenia

Julie Kreyenbuhl(University of Maryland, Baltimore), Lisa B. Dixon(Dixon University Center), Deborah R. Medoff(University of Maryland, Baltimore), Eric P. Slade(University of Maryland, Baltimore), Benjamin Ehrenreich(University of Maryland, Baltimore), Joseph Afful(Centers for Disease Control and Prevention)
Schizophrenia Research
May 21, 2011
10.1016/j.schres.2011.04.028
Cited by 62

Related Papers

The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|781
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
|Schizophrenia Bulletin|2004|768
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
|Schizophrenia Bulletin|2009|501
Disengagement From Mental Health Treatment Among Individuals With Schizophrenia and Strategies for Facilitating Connections to Care: A Review of the Literature
|Schizophrenia Bulletin|2009|448